Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

38.41
-0.2000-0.52%
Post-market: 37.00-1.4100-3.67%19:30 EDT
Volume:2.49M
Turnover:95.81M
Market Cap:3.70B
PE:-19.64
High:39.25
Open:38.88
Low:38.15
Close:38.61
52wk High:42.68
52wk Low:25.27
Shares:96.27M
Float Shares:94.37M
Volume Ratio:4.15
T/O Rate:2.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9561
EPS(LYR):-1.2849
ROE:-16.22%
ROA:-11.54%
PB:3.08
PE(LYR):-29.89

Loading ...

IDEAYA Biosciences announces annual shareholder meeting

Reuters
·
Apr 30

IDEAYA And AstraZeneca Collaboration Adds New Dimension To IDE849 And Valuation

Simply Wall St.
·
Apr 22

IDEAYA to present complete OptimUM-02 darovasertib-crizotinib trial data at ASCO 2026

Reuters
·
Apr 21

IDEAYA Biosciences Inc : JP Morgan Raises Target Price to $81 From $78

THOMSON REUTERS
·
Apr 15

IDEAYA Biosciences Inc : Stephens Raises Target Price to $48 From $45

THOMSON REUTERS
·
Apr 15

Ideaya Biosciences Stock Not Fully Reflecting Phase 2/3 Data From Metastatic Uveal Melanoma Study, RBC Says

MT Newswires Live
·
Apr 14

IDEAYA Biosciences Is Maintained at Buy by Guggenheim

Dow Jones
·
Apr 14

Ideaya Biosciences price target raised to $54 from $50 at Guggenheim

TIPRANKS
·
Apr 14

IDEAYA Biosciences Inc : Truist Securities Raises Target Price to $65 From $60

THOMSON REUTERS
·
Apr 14

IDEAYA Biosciences, Inc. : Wells Fargo Raises Target Price to $48 From $44

THOMSON REUTERS
·
Apr 14

U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines

Reuters
·
Apr 14

IDEAYA Biosciences Inc : Leerink Partners Raises Target Price to $37 From $34

THOMSON REUTERS
·
Apr 14

IDEAYA Biosciences Inc : Guggenheim Raises Target Price to $54 From $50

THOMSON REUTERS
·
Apr 14

Ideaya Biosciences price target raised to $65 from $60 at Truist

TIPRANKS
·
Apr 14

BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune

Reuters
·
Apr 14

BUZZ-U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma

Reuters
·
Apr 13

IDEAYA Biosciences Up Over 17%, on Pace for Largest Percent Increase Since April 2023 -- Data Talk

Dow Jones
·
Apr 13

Wedbush Adjusts Price Target on IDEAYA Biosciences to $58 From $52, Maintains Outperform Rating

MT Newswires Live
·
Apr 13

Ideaya Biosciences rises 22.8%

TIPRANKS
·
Apr 13

IDEAYA Biosciences Shares Rise 13% After Co's Eye Cancer Drug Combo Improves Survival in Trial

THOMSON REUTERS
·
Apr 13